Trident Life Sciences Ltd. Report issue

For profit Phase 1
Founded: Hyderabad India (2004)
Status: Acquired by Aurobindo Pharma (2009)

Organization Overview

First Clinical Trial
2008
NCT01375452
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 1 Trials (2)

amlodipine (norvasc) (2 trials)

letrozole (femara) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malnutrition (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 4
  • # of Trial APIs: 2